May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Indo Cannabis concentrated 47.41% of May 2026 sales in Capsules and 32.91% in Topical, with Vapor Pens at 19.69%; within this mix, Capsules contracted by 47.38% year over year and 13.93% month over month, while Topical declined 13.78% YoY and 10.85% MoM. In contrast, Vapor Pens expanded 475.78% YoY but fell 34.89% MoM, indicating volatility even as the category’s share climbed to nearly one-fifth; the brand’s average price eased 2.03% YoY to $27.16, and the Capsules average price sat at $27.41. This pattern implies a shift away from legacy Capsules toward a still-unstable Vapor Pens contribution, reducing dependence on a shrinking anchor while creating near-term variability in month-to-month revenue.
Despite Capsules holding the top category share, Indo Cannabis sits at rank 2 in Capsules in Nevada, and the category’s 47.38% YoY contraction alongside a 13.93% MoM slide suggests headroom is coming more from mix reallocation than from category recovery; Topical’s 13.78% YoY and 10.85% MoM declines reinforce that point. The 475.78% YoY surge in Vapor Pens paired with a 34.89% MoM drop indicates trial-led gains that are not yet retained, and the 2.03% YoY decrease in average price signals price elasticity being tested without preventing share migration toward Vapor Pens. The implication is that Indo Cannabis is repositioning toward inhalable formats to offset Capsule softness while it calibrates pricing and retention mechanics to stabilize the new base.
Competitive Landscape
Indo Cannabis sits at rank #2 in NV Capsules in May 2026, unchanged from #2 year over year, and unchanged from #2 three months ago; this stability follows a prior peak at #1 in November 2025, implying a one-rank slide from peak to present. Leader Level holds #1 now and also held #1 a year ago, yet its sales fell 48.9% year over year, while Cannavative sits at #4 with a 68.4% year-over-year sales decline; this places Indo Cannabis between a contracting leader and a faster-falling follower. The pattern of a flat #2 rank alongside competitors with double-digit sales declines indicates Indo Cannabis is defending a stable share position relative to peers, pointing to a consolidation phase rather than a growth surge.

Notable Products
IndoPuff- Blueberry Punch Distillate Disposable (1g) posted the headline movement in May 2026 with a 65.3% month-over-month gain and a rank of 7, contrasting with Acapulco Gold Distillate Cartridge (1g) dropping 29.1% to rank 10. At the top of the table, CBD/CBN/THC 4:4:1 Jungle Stick IndoBalm (400mg CBD, 400mg CBN, 100mg THC) slipped 8.4% yet held rank 1, while its sibling CBD/THC/CBN 4:4:1 Jungle Stick Balm (400mg CBD, 400mg THC, 100mg CBN) fell 13.5% at rank 2, indicating topical leadership is intact but softening at the margin. Capsules dominate with five of the top ten but show dispersion: Maxtabs - THC Capsules 10-Pack (100mg) declined 19.2% at rank 3 as the Indotabs -THC Infused Tablet 30-Pack (600mg) slid 34.5% at rank 9, while THC Maxtabs 2-Pack (200mg) nearly offset category pressure with a 49.4% rise at rank 5 and $6,166 in sales. The mix implies Indo Cannabis is pivoting toward faster-moving, convenience formats as vapor pens rebound and smaller-pack capsules gain share while larger-pack capsules and legacy topicals give back momentum.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







